🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
14/12/2018 0,5248 USD
14/09/2018 0,4580 USD
14/06/2018 0,4580 USD
14/03/2018 0,4580 USD
14/12/2017 0,4580 USD
14/09/2017 0,4485 USD
13/06/2017 0,4485 USD
13/03/2017 0,4485 USD
13/12/2016 0,4485 USD
13/09/2016 0,4389 USD
13/06/2016 0,4389 USD
11/03/2016 0,4389 USD
11/12/2015 0,4389 USD
11/09/2015 0,4294 USD
11/06/2015 0,4294 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/10/2016 59,90 60,11 59,19 59,90 +0,18% 1,53% 11.292.410
06/10/2016 59,63 59,82 58,91 59,79 -0,22% 1,52% 11.979.164
05/10/2016 59,83 60,15 59,62 59,92 +0,54% 0,89% 8.249.122
04/10/2016 59,62 60,07 59,10 59,60 -0,10% 1,62% 8.276.475
03/10/2016 59,37 59,70 58,85 59,66 +0,18% 1,45% 7.881.065
30/09/2016 59,06 59,86 59,03 59,55 +0,81% 1,41% 14.258.354
29/09/2016 60,13 60,13 58,74 59,07 -2,20% 2,32% 11.454.640
28/09/2016 60,11 60,57 59,64 60,40 +1,17% 1,56% 12.361.160
27/09/2016 59,46 59,83 59,00 59,70 +0,68% 1,40% 7.693.158
26/09/2016 59,67 59,71 59,05 59,30 -1,29% 1,12% 7.319.022
23/09/2016 59,99 60,35 59,83 60,08 -0,10% 0,87% 8.048.430
22/09/2016 60,04 60,56 59,95 60,13 +0,51% 1,02% 8.853.294
21/09/2016 59,41 59,94 59,03 59,83 +1,23% 1,54% 7.565.512
20/09/2016 59,06 59,55 58,86 59,10 +0,99% 1,16% 9.653.757
19/09/2016 59,68 59,68 58,51 58,52 -1,53% 1,95% 11.829.510
16/09/2016 59,59 59,75 59,22 59,43 -0,16% 0,90% 13.029.050
15/09/2016 58,44 59,74 58,32 59,52 +1,68% 2,43% 9.429.694
14/09/2016 59,08 59,48 58,49 58,54 -0,74% 1,68% 10.922.046
13/09/2016 59,51 59,90 58,56 58,98 -2,18% 2,26% 10.714.123
12/09/2016 59,16 60,58 59,07 60,30 +1,12% 2,55% 11.139.716
09/09/2016 59,82 59,84 59,47 59,63 -1,19% 0,62% 13.191.700
08/09/2016 59,59 60,39 59,48 60,34 +0,59% 1,54% 9.627.242
07/09/2016 60,41 60,58 59,73 59,99 -0,58% 1,41% 9.084.169
06/09/2016 60,11 60,56 59,90 60,34 +0,41% 1,11% 8.310.954
02/09/2016 59,72 60,37 59,72 60,10 +0,13% 1,09% 7.978.634
01/09/2016 59,83 60,10 59,53 60,02 +0,18% 0,94% 6.858.846
31/08/2016 60,19 60,23 59,56 59,91 +0,13% 1,11% 9.285.804
30/08/2016 60,08 60,14 59,65 59,84 -0,48% 0,83% 6.474.544
29/08/2016 60,04 60,39 59,77 60,12 +0,25% 1,03% 5.843.438
26/08/2016 59,62 60,11 59,33 59,97 +0,85% 1,30% 8.167.902